{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:15:13Z","timestamp":1783692913673,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["276747"],"award-info":[{"award-number":["276747"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["284504"],"award-info":[{"award-number":["284504"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["312611"],"award-info":[{"award-number":["312611"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.atherosclerosis.2025.120549","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T06:42:40Z","timestamp":1760683360000},"page":"120549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?"],"prefix":"10.1016","volume":"411","author":[{"given":"Elisa","family":"Koljonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"K\u00e4rkk\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retu","family":"Haikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Turpeinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Rys\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.120549_bib1","doi-asserted-by":"crossref","unstructured":"S. Yagdir et al., Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017, (n.d.). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043391.","DOI":"10.1161\/CIRCULATIONAHA.119.043391"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. The troms\u00f8 study","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart"},{"issue":"Suppl E","key":"10.1016\/j.atherosclerosis.2025.120549_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/9.suppl_E.57","article-title":"The natural history of aortic valve stenosis","volume":"9","author":"Horstkotte","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib5","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","article-title":"Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study","volume":"37","author":"d'Arcy","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib6","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis","volume":"63","author":"Coffey","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacc.2019.10.050","article-title":"Obesity as a causal risk factor for aortic valve stenosis","volume":"75","author":"Kaltoft","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","article-title":"Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis","volume":"113","author":"Katz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor ramipril in aortic stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ehjci\/jew335","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography","volume":"18","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis \u2014 from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic technologies","volume":"186","author":"W\u00fcrtz","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib16","series-title":"Reprint","article-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"2009"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000021992","article-title":"Lipoprotein profile and high-density lipoproteins: subfractions distribution in centenarians","volume":"44","author":"Barbagallo","year":"1998","journal-title":"Gerontology"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib18","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.3390\/ijerph20216994","article-title":"Factors associated with low albumin in community-dwelling older adults aged 75 years and above","volume":"20","author":"Kobayashi","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/01.ATV.13.11.1654","article-title":"Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses","volume":"13","author":"Williams","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00705034","article-title":"Effects of age and physical performance capacity on distribution and composition of high-density lipoprotein subfractions in men","volume":"60","author":"Frey","year":"1990","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib22","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease: the framingham study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib26","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib27","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib28","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjp.2008.122","article-title":"Regression of aortic valve stenosis by apoa-i mimetic peptide infusions in rabbits","volume":"154","author":"Busseuil","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/bph.12236","article-title":"Improvement of aortic valve stenosis by ApoA \u2010 I mimetic therapy is associated with decreased aortic root and valve remodelling in mice","volume":"169","author":"Trapeaux","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib31","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/eurheartj\/ehq064","article-title":"Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model","volume":"31","author":"Speidl","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib32","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2010.03.019","article-title":"Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium","volume":"55","author":"Thanassoulis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/ATVBAHA.122.318004","article-title":"High-density lipoprotein and long-term incidence and progression of aortic valve calcification: the multi-ethnic study of atherosclerosis","volume":"42","author":"Bortnick","year":"2022","journal-title":"ATVB"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1253\/circj.CJ-20-1090","article-title":"For the Shiga epidemiological study of subclinical atherosclerosis (SESSA) research group, lipoprotein particle profiles compared with standard lipids in the association with subclinical aortic valve calcification in apparently healthy Japanese men","volume":"85","author":"Vu","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/ATVBAHA.113.302730","article-title":"Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans","volume":"34","author":"Arsenault","year":"2014","journal-title":"ATVB"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.34.4.679","article-title":"Ischemic heart disease, atherosclerosis, and longevity","volume":"34","author":"Gofman","year":"1966","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/ije\/dyab156","article-title":"Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships","volume":"51","author":"Ala-Korpela","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/msb.2010.93","article-title":"Metabonomic, transcriptomic, and genomic variation of a population cohort","volume":"6","author":"Inouye","year":"2010","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.atherosclerosis.2016.06.019","article-title":"Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial","volume":"251","author":"Albers","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jacl.2018.12.002","article-title":"Small HDL subclass is associated with coronary plaque stability: an optical coherence tomography study in patients with coronary artery disease","volume":"13","author":"Wang","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2016.06.010","article-title":"Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample","volume":"251","author":"Ditah","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000902","article-title":"HDL\u20103 is a superior predictor of carotid artery disease in a case\u2010control cohort of 1725 participants","volume":"3","author":"Kim","year":"2014","journal-title":"JAHA"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib45","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density Lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"ATVB"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132698","article-title":"Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis","volume":"419","author":"Gigante","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacl.2012.03.001","article-title":"High-density lipoprotein subclasses and their relationship to cardiovascular disease","volume":"6","author":"Superko","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fphar.2017.00989","article-title":"Pharmacological intervention to modulate HDL: what do we target?","volume":"8","author":"Woudberg","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib49","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.123.065959","article-title":"Flipped C-Terminal ends of APOA1 promote ABCA1-Dependent cholesterol efflux by small HDLs","volume":"149","author":"He","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2025-326161","article-title":"Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies","author":"Xiang","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib52","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER database","volume":"51","author":"Barter","year":"2010","journal-title":"JLR (J Lipid Res)"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(02)00149-1","article-title":"Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients","volume":"164","author":"Asztalos","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.amjcard.2006.09.117","article-title":"Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins","volume":"99","author":"Asztalos","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib55","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.2337\/dc06-1903","article-title":"On behalf of the GLAI study investigators, pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia","volume":"30","author":"Deeg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d1309","article-title":"Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies","volume":"342","author":"Loke","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa020194","article-title":"Effects of the amount and intensity of exercise on plasma lipoproteins","volume":"347","author":"Kraus","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","article-title":"Low serum albumin: a neglected predictor in patients with cardiovascular disease","volume":"102","author":"Manolis","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/aca.aca_114_21","article-title":"Pre-procedural serum albumin concentration is associated with length of stay, discharge destination, and 90-Day mortality in patients after transcatheter aortic valve replacement","volume":"26","author":"Beydoun","year":"2023","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-012-0802-0","article-title":"Hypoalbuminemia","volume":"7","author":"Gatta","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib61","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.clnu.2021.01.018","article-title":"Greater protein intake at breakfast or as snacks and less at dinner is associated with cardiometabolic health in adults","volume":"40","author":"Berryman","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00216-006-0687-8","article-title":"Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics","volume":"387","author":"Pan","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib63","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/b418288j","article-title":"Measuring the metabolome: current analytical technologies","volume":"130","author":"Dunn","year":"2005","journal-title":"Analyst"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib64","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ejhf.3226","article-title":"Serum metabolomics improves risk stratification for incident heart failure","volume":"26","author":"Oexner","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.123.066523","article-title":"Reactivation of oxidized soluble guanylate cyclase as a novel treatment strategy to slow progression of calcific aortic valve stenosis: preclinical and randomized clinical trials to assess safety and efficacy","volume":"151","author":"Zhang","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120549_bib66","series-title":"Metabolic signatures of blood pressure and risk of cardiovascular diseases","author":"Manou","year":"2024"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:30:38Z","timestamp":1783690238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025014479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"alternative-id":["S0021915025014479"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120549","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120549"}}